Registration successful.
Account activated – Pending validation
Your account has been activated successfully, but we still need to validate you as a UK healthcare professional. We’ll send you an email with the result. Please note this could take up to 10 days.
In the meantime, you can enjoy access to all the latest news, events and resources on our website.
Professor Alvar Agusti
Professor Alvar Agusti, Chair of the Board of Directors of GOLD, talks about the updates to the GOLD 2023 report for symptomatic COPD patients. Please note, the GOLD 2023 report has been updated as of 2024
Use of GOLD content in this video © 2023 Global Strategy for the Diagnosis, Management and Prevention of COPD. All rights reserved. Use is by express license from the owner.
GOLD recommends classes of medicines, not specific products.
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on 0800 221 441 or UKSafety@GSK.com.
February 2024 | PM-GB-UCV-WCNT-230032 (V1.0)
